M&A WATCH- Ibnsina Pharma is looking potential investments in unnamed pharma manufacturing companies through a newly-established special purpose vehicle (SPV), according to an EGX disclosure (pdf). The company is studying “a number” of potential investments and is closing in on signing non-binding offers for the purchase of minority stakes.
More from Enterprise
BdC’s 3Q net income falls 20% y-o-y, while 9M income rises 5%
Provisions more than doubled q-o-q to EGP 1.09 bn, dragging…
Africa’s own credit rating agency plans its first rating by March 2027, and our central bank has long backed it
Its early value lies in 22 sovereigns nobody rates, and…
OG Capital raises its capital to EGP 100 mn, but its six-month deadline arrives with no acquisition target named
Here are the stories driving the day, both at home…
Thndr’s Ahmad Hammouda on why the app wants to make the listings it trades
CEO Hammouda’s model is to sign companies years before they…